Theseus Pharmaceuticals, Inc. (THRX) has 20 known insider and institutional holders on record. The largest holder is GLAXOSMITHKLINE PLC with 30,258,302 shares. Other notable holders include Foresite Capital Management V, LLC and Winningham Rick E.
THRX Insider Ownership
Top Holder
GLAXOSMITHKLINE PLC
30,258,302 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Glaxosmithkline Plc |
Director |
30,258,302 |
2014-02-13 |
|
| 2 |
Foresite Capital Management V, Llc |
10 Percent Owner |
1,385,825 |
2023-07-19 |
|
| 3 |
Winningham Rick E |
Director |
825,391 |
2014-08-19 |
|
| 4 |
Gordon Carl L |
10 Percent Owner |
650,600 |
2023-07-19 |
|
| 5 |
Orbimed Advisors Llc |
10 Percent Owner |
650,600 |
2023-07-19 |
|
| 6 |
Aguiar Michael W |
President & CEO |
432,653 |
2015-06-04 |
|
| 7 |
Blum Leonard M |
Sr VP, Chief Comm. Officer |
401,538 |
2014-08-22 |
|
| 8 |
Shafer Bradford J |
Sr VP, Gen. Counsel, Secretary |
337,624 |
2012-08-22 |
|
| 9 |
Glick Marty |
Executive VP, Finance and CFO |
267,805 |
2004-10-07 |
|
| 10 |
Lee Junning |
Sr. VP, Technical Operations |
209,887 |
2014-06-04 |
|
| 11 |
Mammen Mathai |
SVP, Research & Early Clin Dev |
186,623 |
2014-02-19 |
|
| 12 |
Dalgarno David |
Chief Technical Officer |
130,000 |
2022-02-23 |
|
| 13 |
Waltrip William H |
Director |
123,604 |
2015-05-29 |
|
| 14 |
Faerm Michael E. |
Sr VP & Chief Business Officer |
105,288 |
2015-07-27 |
|
| 15 |
Desparbes Eric |
SVP and CFO |
102,471 |
2014-10-17 |
|
| 16 |
Shakespeare William |
See Remarks |
93,260 |
2023-11-07 |
|
| 17 |
Abercrombie George B |
Sr. VP, Corp. Partnerships |
81,429 |
2015-01-09 |
|
| 18 |
Witek Theodore L Jr |
Sr. VP, Corp Partnerships |
71,429 |
2015-02-23 |
|
| 19 |
Brinkley David L |
Head of Business Dev. |
48,749 |
2013-05-31 |
|
| 20 |
Clackson Timothy P |
President and CEO |
45,625 |
2023-03-02 |
|
No ownership data available for THRX.
